ArticleLeukemia2020

CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition.

Miguel Quijada-Álamo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.